Facebook Linkedin RSS Twitter Youtube
Home 2024

Vision disorders

AAV Gene Therapy for LCA1 Improves Vision Dramatically
Drug Discovery

AAV Gene Therapy for LCA1 Improves Vision Dramatically

Gene Editing for Inherited Form of Blindness Shows Promise in Phase I/II Trial
Genome Editing

Gene Editing for Inherited Form of Blindness Shows Promise in Phase I/II Trial

Retinal Degeneration Could Be Slowed by Anti-Inflammatory Hydrogel
Drug Discovery

Retinal Degeneration Could Be Slowed by Anti-Inflammatory Hydrogel

Neurodegenerative Disease Could Be Treated by Using Pexophagy to Limit Autophagy
News

Neurodegenerative Disease Could Be Treated by Using Pexophagy to Limit Autophagy

Human Glia Reprogrammed into Neuron-Generating Cells
Featured

Human Glia Reprogrammed into Neuron-Generating Cells

Prime Medicine Presents First In Vivo Prime Editing Data to Treat Ophthalmological Diseases
Genome Editing

Prime Medicine Presents First In Vivo Prime Editing Data to Treat Ophthalmological Diseases

Vitreoretinal Diseases May Find Treatment in Exosome-Loaded Microcapsules
Drug Discovery

Vitreoretinal Diseases May Find Treatment in Exosome-Loaded Microcapsules

Prime Editing Reverses Vision Loss in Mice
News

Prime Editing Reverses Vision Loss in Mice

Andelyn Biosciences and Odylia Therapeutics Partner to Manufacture Novel Gene Therapy for Vision Loss
Bioprocessing

Andelyn Biosciences and Odylia Therapeutics Partner to Manufacture Novel Gene Therapy for Vision Loss

3D Bioprinting and Stem Cells Help Create Model of Eye Diseases
News

3D Bioprinting and Stem Cells Help Create Model of Eye Diseases

1234Page 1 of 4
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.